What changed
OpenAI said GPT-Rosalind, its specialized model for life sciences research, is now out of research preview and available globally to eligible organizations through its trusted-access program. The model is offered in ChatGPT, Codex, and the API for qualified customers.
Why it matters
Domain-specific models can be easier to operationalize than general-purpose frontier systems when the task is literature review, hypothesis generation, or research workflow support in a narrow field.
Developer takeaway
For biotech and pharma teams, this creates a concrete benchmark against your current stack. OpenAI said published pricing took effect on October 5, 2026, so cost comparisons can now be part of procurement and pilot planning rather than speculation.